admin | Regenerative Medicine Foundation

A New CRISPR Cancer Treatment Has Been Tested On Humans For The First Time – And The Results Are Promising

by admin | Dec 7, 2022 | News & Opinions

by Rameesha Sajwar – Wonderful Engineering Gene-editing technology CRISPR has been used to remove genes from immune system cells to make them better at fighting cancer. Recently, PACT Pharma and UCLA have used CRISPR to remove and add genes to these cells to...

USC and CHLA awarded million to expand access to cell and gene therapy clinical trials

USC and CHLA awarded $8 million to expand access to cell and gene therapy clinical trials

by admin | Dec 6, 2022 | News & Opinions

CIRM-funded USC+CHLA Alpha Clinic boosts capacity for clinical and translational research, community outreach, training and manufacturing By Wayne Lewis – Keck School of Medicine of USC The California Institute for Regenerative Medicine (CIRM), the state’s stem...

Secret shopper studies: an unorthodox design that measures inequities in healthcare access

by admin | Dec 5, 2022 | News & Opinions

by Kelsey A. Rankin, Alison Mosier-Mills, Walter Hsiang & Daniel H. Wiznia – BMC Archives of Public Health Abstract Secret shopper studies are particularly potent study designs that allow for the gathering of objective data for a variety of research...

Fitness program for blood stem cells: TAZ protein protects from age-related loss of function

by admin | Dec 1, 2022 | News & Opinions

by by Kerstin Wagner, Leibniz-Institut für Alternsforschung – Fritz-Lipmann-Institut e.V. (FLI) – Phys.org Image: Hematopoietic stem cells age very heterogeneously. The TAZ protein, a co-activator of the Hippo signaling pathway, can protect blood stem...

Human synovial mesenchymal stem cells show time-dependent morphological changes and increased adhesion to degenerated porcine cartilage